Stockreport

BioNTech co-founders set to launch new mRNA venture as company sharpens oncology focus [Yahoo! Finance]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF BioNTech SE (NASDAQ:BNTX) co-founders Ugur Sahin and Özlem Türeci plan to launch a new independent biotech company focused on next-generation mRNA technologies, the Ger [Read more]